Since this scoring system provides a composite of adverse effects manifested by common immunosuppression regimens, additional factors such as concomitant medications or co-morbidities should also be considered during routine clinical assessment.
The synthetic estrogen diethylstilbestrol (DES), prescribed from the 1940s to the 1970s to prevent miscarriage, is recognized as a seminal example of a human transplacental carcinogen for the multitude of adverse effects manifested in adult offspring.
The health effects associated with early-life ETS exposure include reduced fetal growth, neurodevelopmental problems, respiratory disease including asthma, increased cancer risk, and cardiovascular disease, with some adverse effects manifesting in childhood and others in adulthood (Samet 2005; U.S. Department of Health and Human Services 2006).
The concentration at which these adverse effects are manifested depends on the structure of the surfactant used and the nature of the microorganism.
An old study that assessed the safety of intramuscularly administered colistimethate sodium during 317 courses revealed that neurological adverse effects were manifested during the first four days of therapy in 83% of the patients who experienced neurotoxic events [ 4].
This involves identifying and managing adverse effects that manifest both mentally and physically.
Even if a SECNT embryo survives, permanent adverse effects are often manifested as abnormalities such as large-offspring syndrome, placental enlargement, adiposity, respiratory defects, and immune defects, all of which result in a shortened lifespan [22], [23], [24], [25], [26].
The adverse effects can be manifested in attenuated effects of exercise and training, as the antioxidants may shut down some redox-sensitive signaling in the exercised muscle fibers.
Adverse effects include akathisia (manifested as restlessness) in 20% and acute dystonic reactions (rigid muscles and involuntary movements) for about 2% of patients.
In particular, low-dose ketamine (0.5 or 1 mg/kg) administered prior to surgical incision is unlikely to be associated with major adverse events, and even minor side effects manifesting after induction of anaesthesia and the start of surgery are improbable.
The Secretary shall by regulation establish a table identifying covered injuries that shall be presumed to be directly caused by the administration or use of a covered countermeasure and the time period in which the first symptom or manifestation of onset of each such adverse effect must manifest in order for such presumption to apply.
